The universities of Cambridge and Manchester, Imperial College London and the SETsquared Partnership, a joint venture among four universities in southern England, have won funding to collaborate with peers in the US and with companies such as Airbus and Boeing.
Nanonucleant, a spin-out of Imperial College London, is seeking angel financing to move ahead with a glass grain-based technology that aids in crystallising proteins for study as drug targets.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.